Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Valvular Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 90 articles:
HTML format



Single Articles


    July 2021
  1. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    


    March 2021
  2. BERWANGER O, Guimaraes HP, Lopes RD
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.
    N Engl J Med. 2021;384:975-976.
    PubMed    


  3. DURAES AR, Bitar YSL
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:975.
    PubMed    


  4. ALGHAMRY A, Lee JC
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974-975.
    PubMed    


  5. LOTLIKAR A, Anwar S
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974.
    PubMed    


  6. VERMA A, Dhingra N, Yanagawa B
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:973-974.
    PubMed    


    January 2021
  7. BROUWER J, Nijenhuis VJ, Ten Berg JM
    Single or Dual Antiplatelet Treatment after TAVI. Reply.
    N Engl J Med. 2021;384:90-91.
    PubMed    


  8. FAHRNI G, Jeger R, Mueller C
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    


  9. EIKELBOOM R, Belley-Cote EP, Whitlock RP
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    


  10. ANWAR S, Spence E, Zawadka M
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:89-90.
    PubMed    


    November 2020
  11. GUIMARAES HP, Lopes RD, de Barros E Silva PGM, Liporace IL, et al
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2020 Nov 14. doi: 10.1056/NEJMoa2029603.
    PubMed     Abstract available


    October 2020
  12. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  13. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    


    August 2020
  14. BROUWER J, Nijenhuis VJ, Delewi R, Hermanides RS, et al
    Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Aug 30. doi: 10.1056/NEJMoa2017815.
    PubMed     Abstract available


  15. VAN BELLE E, Labreuche J, Vincent F
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:596.
    PubMed    


  16. MAKKAR RR, Mack MJ, Leon MB
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:595-596.
    PubMed    


  17. KHOKHAR AA, Giannini F, Colombo A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594-595.
    PubMed    


  18. BARILI F, Freemantle N, Parolari A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594.
    PubMed    


    July 2020
  19. DANGAS GD, De Backer O, Windecker S
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:e8.
    PubMed    


  20. ALGHAMRY A, Murdoch DJ
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  21. STOJKOVIC S, Sulzgruber P, Niessner A
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  22. YAHAGI K, Sato Y, Virmani R
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  23. MARTIN AC, Smadja DM, Karam N
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  24. KANG DH, Park SW
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. Reply.
    N Engl J Med. 2020;383:92-93.
    PubMed    


  25. SIDEBOTHAM D, Morrow CD, Drake DH
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:92.
    PubMed    


  26. GARRY JD, Goldman M, Kohlwes J
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:91-92.
    PubMed    


    April 2020
  27. FEIT F
    How Un-POPular Is Bleeding in Patients with TAVI?
    N Engl J Med. 2020;382:1761-1763.
    PubMed    


    March 2020
  28. NIJENHUIS VJ, Brouwer J, Delewi R, Hermanides RS, et al
    Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Mar 29. doi: 10.1056/NEJMoa1915152.
    PubMed     Abstract available


    February 2020
  29. MAKKAR RR, Thourani VH, Mack MJ, Kodali SK, et al
    Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.
    N Engl J Med. 2020;382.
    PubMed     Abstract available


    January 2020
  30. KANG DH, Park SJ, Lee SA, Lee S, et al
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed     Abstract available


  31. LANCELLOTTI P, Vannan MA
    Timing of Intervention in Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed    


  32. NISHIMURA RA, Holmes DR Jr
    Treatment after TAVR - Discordance and Clinical Implications.
    N Engl J Med. 2020;382:193-194.
    PubMed    


    November 2019
  33. FAROOQUI FA, Deepti S
    Myxomatous Mitral-Valve Prolapse.
    N Engl J Med. 2019;381:e37.
    PubMed    


  34. DE BACKER O, Dangas GD, Jilaihawi H, Leipsic JA, et al
    Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911426.
    PubMed     Abstract available


  35. DANGAS GD, Tijssen JGP, Wohrle J, Sondergaard L, et al
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911425.
    PubMed     Abstract available


    October 2019
  36. VEMULAPALLI S, Carroll JD, Mack MJ
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2019;381:1394-1395.
    PubMed    


  37. SHARMA A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1394.
    PubMed    


  38. GOLDBERG SL, Gray RM, Horne A Jr
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393-1394.
    PubMed    


  39. NOBLE S, Frei A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393.
    PubMed    


  40. ACEITUNO J, Ramirez P
    Landolfi's Sign.
    N Engl J Med. 2019;381:e29.
    PubMed    


    September 2019
  41. KREMER TM, Lindsay ME, Kinane TB, Hawley MH, et al
    Case 28-2019: A 22-Year-Old Woman with Dyspnea and Chest Pain.
    N Engl J Med. 2019;381:1059-1067.
    PubMed    


    August 2019
  42. POPMA JJ, Reardon MJ
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply.
    N Engl J Med. 2019;381:685.
    PubMed    


  43. MACK MJ, Leon MB
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply.
    N Engl J Med. 2019;381:684-685.
    PubMed    


  44. SAVAS G, Terzi S, Yesilcimen K
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients.
    N Engl J Med. 2019;381:684.
    PubMed    


  45. PERELLA P, Anwar S
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients.
    N Engl J Med. 2019;381:683-684.
    PubMed    


  46. BALDETTI L, Beneduce A, Gallone G
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients.
    N Engl J Med. 2019;381:682-683.
    PubMed    


  47. KAUL S
    Transcatheter Aortic-Valve Replacement in Low-Risk Patients.
    N Engl J Med. 2019;381:682.
    PubMed    


  48. LAZARETH H, Karras A
    Cholesterol Crystal Embolization after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:655.
    PubMed    


    July 2019
  49. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
    Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
    N Engl J Med. 2019;381:359-369.
    PubMed    


    May 2019
  50. SIMMONS RP, Dudzinski DM, Shepard JO, Hurtado RM, et al
    Case 16-2019: A 53-Year-Old Man with Cough and Eosinophilia.
    N Engl J Med. 2019;380:2052-2059.
    PubMed    


  51. STONE GW, Weissman NJ, Mack MJ
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure. Reply.
    N Engl J Med. 2019;380:1980-1981.
    PubMed    


  52. KALAVROUZIOTIS D, Voisine P, Mohammadi S
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    N Engl J Med. 2019;380:1979-1980.
    PubMed    


  53. GARBI M, Lancellotti P
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    N Engl J Med. 2019;380:1979.
    PubMed    


  54. DRAKE DH, Zimmerman KG, Sidebotham DA
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    N Engl J Med. 2019;380:1978-1979.
    PubMed    


  55. CRESTANELLO JA, Oh JK, Schaff HV
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    N Engl J Med. 2019;380:1978.
    PubMed    


  56. GRINBERG D, Obadia JF, Iung B
    Percutaneous Repair for Secondary Mitral Regurgitation. Reply.
    N Engl J Med. 2019;380:1977-1978.
    PubMed    


  57. SILVERIO A, Baldi C, Citro R
    Percutaneous Repair for Secondary Mitral Regurgitation.
    N Engl J Med. 2019;380:1976-1977.
    PubMed    


  58. GOLIASCH G, Bartko PE, Hulsmann M
    Percutaneous Repair for Secondary Mitral Regurgitation.
    N Engl J Med. 2019;380:1976.
    PubMed    


  59. GODINO C, Munafo A, Margonato A
    Percutaneous Repair for Secondary Mitral Regurgitation.
    N Engl J Med. 2019;380:1975-1976.
    PubMed    


  60. MURDOCH DJ, Webb JG, Ye J, Sathananthan J, et al
    Transcatheter Aortic-Valve Replacement - 10 Years Later.
    N Engl J Med. 2019;380:1773-1774.
    PubMed    


  61. OTTO CM
    Informed Shared Decisions for Patients with Aortic Stenosis.
    N Engl J Med. 2019;380:1769-1770.
    PubMed    


    April 2019
  62. BERG DD, Kirshenbaum JM, Gay E, Miller AL, et al
    A Dangerous Detour.
    N Engl J Med. 2019;380:1360-1365.
    PubMed    


  63. VEMULAPALLI S, Carroll JD, Mack MJ, Li Z, et al
    Procedural Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Apr 3. doi: 10.1056/NEJMsa1901109.
    PubMed     Abstract available


    March 2019
  64. BERG DD, Kirshenbaum J, Gay E, Vaidya A, et al
    A Dangerous Detour.
    N Engl J Med. 2019;380:e18.
    PubMed    


  65. MACK MJ, Leon MB, Thourani VH, Makkar R, et al
    Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1814052.
    PubMed     Abstract available


  66. POPMA JJ, Deeb GM, Yakubov SJ, Mumtaz M, et al
    Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1816885.
    PubMed     Abstract available


    December 2018
  67. NISHIMURA RA, Bonow RO
    Percutaneous Repair of Secondary Mitral Regurgitation - A Tale of Two Trials.
    N Engl J Med. 2018;379:2374-2376.
    PubMed    


  68. ISSELBACHER EM, Meyersohn NM, Sarma AA, Spooner AE, et al
    Case 38-2018: A 54-Year-Old Man with New Heart Failure.
    N Engl J Med. 2018;379:2362-2372.
    PubMed    


    November 2018
  69. PASCOE SJ
    Clinical Course and Management of Hypertrophic Cardiomyopathy.
    N Engl J Med. 2018;379:1976-7.
    PubMed    


  70. BACHMAYER K
    Clinical Course and Management of Hypertrophic Cardiomyopathy.
    N Engl J Med. 2018;379:1976.
    PubMed    


  71. MARON BJ
    Clinical Course and Management of Hypertrophic Cardiomyopathy.
    N Engl J Med. 2018;379:1977.
    PubMed    


    September 2018
  72. LILIC N
    Murmurs of Politics and Economics.
    N Engl J Med. 2018;379:1202-1203.
    PubMed    


  73. STONE GW, Lindenfeld J, Abraham WT, Kar S, et al
    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.
    N Engl J Med. 2018 Sep 23. doi: 10.1056/NEJMoa1806640.
    PubMed     Abstract available


    August 2018
  74. OBADIA JF, Messika-Zeitoun D, Leurent G, Iung B, et al
    Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1805374.
    PubMed     Abstract available


  75. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Abstract available


  76. MARON BJ
    Clinical Course and Management of Hypertrophic Cardiomyopathy.
    N Engl J Med. 2018;379:655-668.
    PubMed    


  77. MICHELENA HI, Enriquez-Sarano M
    Corrigan's Pulse and Quincke's Pulse.
    N Engl J Med. 2018;379:e9.
    PubMed    


    July 2018
  78. IMRAN TF, Awtry EH
    Severe Mitral Stenosis.
    N Engl J Med. 2018;379:e6.
    PubMed    


    February 2018

  79. Prosthesis Type for Aortic- and Mitral-Valve Replacement.
    N Engl J Med. 2018;378:776-779.
    PubMed    


  80. CHIKWE J, Blackstone EH, Adams DH
    Prosthesis Type for Aortic- and Mitral-Valve Replacement.
    N Engl J Med. 2018;378:778.
    PubMed    


  81. BOURGUIGNON T, Espitalier F, Aupart M
    Prosthesis Type for Aortic- and Mitral-Valve Replacement.
    N Engl J Med. 2018;378:777-8.
    PubMed    


  82. RAZA S, Kalra A, Sabik JF III
    Prosthesis Type for Aortic- and Mitral-Valve Replacement.
    N Engl J Med. 2018;378:777.
    PubMed    


  83. MCGREGOR CGA, Byrne GW
    Prosthesis Type for Aortic- and Mitral-Valve Replacement.
    N Engl J Med. 2018;378:776-7.
    PubMed    


    November 2017
  84. GOLDSTONE AB, Chiu P, Baiocchi M, Lingala B, et al
    Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement.
    N Engl J Med. 2017;377:1847-1857.
    PubMed     Abstract available


    July 2017
  85. NOBLE S, Burri H, Roffi M
    Surgical or Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2017;377:196-7.
    PubMed    


  86. REARDON MJ, Van Mieghem NM, Popma JJ
    Surgical or Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2017;377:197-198.
    PubMed    


  87. MICELI A, Lio A, Glauber M
    Surgical or Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2017;377:196.
    PubMed    



  88. Surgical or Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2017;377:195-196.
    PubMed    


    March 2017
  89. REARDON MJ, Van Mieghem NM, Popma JJ, Kleiman NS, et al
    Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1700456.
    PubMed     Abstract available


    September 2016
  90. DEVY L, Brunet-Possenti F
    IMAGES IN CLINICAL MEDICINE. Cholesterol Embolization after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2016;375:e25.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: